S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.05%) $0.791
USD/RUB
(0.86%) $85.73

Обновления в реальном времени для Sarepta Therapeutics, [0L35.L]

Биржа: London Stock Exchange Сектор: Healthcare Промышленность: Medical - Pharmaceuticals
Последнее обновление28 июнь 2024 @ 20:55

1.37% $ 158.65

Live Chart Being Loaded With Signals

Commentary (28 июнь 2024 @ 20:55):
Our systems believe the stock currently is overvalued by -1.19% compare to its pairs and should correct downwards.
Profile picture for Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases...

Stats
Объем за сегодня 351
Средний объем 424
Рыночная капитализация 15.00B
EPS $0.380 ( Q1 | 2024-05-01 )
Дата следующего отчета о доходах ( $0 ) 2024-07-30
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -37.02
(Sector) 0
(Industry) 0
ATR14 $0.971 (0.62%)